copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
News Releases - CSL About CSL Behring CSL Behring is a global biotherapeutics leader driven by its promise to save lives Focused on serving patients’ needs by using the latest technologies, we develop and deliver innovative therapies that are used to treat coagulation disorders, primary immune deficiencies, hereditary angioedema, inherited respiratory disease, and neurological disorders
Worldwide Locations - CSL Biotech leader CSL has manufacturing centers, sales offices, and locations to serve patients and public health around the globe
Global Biotechnology Company - CSL CSL Behring is a global biotherapeutics leader driven by our promise to save lives Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas
Global Biotechnology Company | CSL CSL Always Evolving for a Better World CSL has delivered biotechnology excellence for over a century Today, with the combined expertise of CSL Behring, CSL Plasma, CSL Seqirus and CSL Vifor, CSL’s offerings are more diverse than ever to help ensure patients and people everywhere get the treatments they need
Expanding Cell- and Gene-Therapy Capability in the U. S. - CSL Driven by its promise to patients, CSL Behring is expanding the company's U S hub for cell- and gene-therapy in Pasadena, California, with added lab and office space to enhance innovation
U. S. Food and Drug Administration Approves CSLs ANDEMBRY® (garadacimab . . . ANDEMBRY inhibits the top of the HAE cascade by targeting factor XIIa and provides sustained protection from attacks Once-monthly dosing reduced HAE attacks by a median of more than 99 percent and a least squares mean of 89 2 percent, compared to placebo ANDEMBRY approval expands CSL's HAE franchise
Product Pipeline - CSL CSL is a global leader in developing and delivering high quality medicines that treat people with rare and serious diseases Working every day as if people’s lives depend on it, CSL’s R D fuels the company’s sustainable growth by advancing world-class science, technology and collaboration